20.06.2018
Credit Suisse Securities (Europe) Limited DE000BAY0017
DGAP-News: Post Stab Notice - Bayer AG capital Re-Org
DGAP-News: Credit Suisse Securities (Europe) Limited / Key word(s):
Miscellaneous
Post Stab Notice - Bayer AG capital Re-Org
20.06.2018 / 08:00
The issuer is solely responsible for the content of this announcement.
---------------------------------------------------------------------------
20/06/2018
Not for distribution, directly or indirectly, in or into the United States
or any jurisdiction in which such distribution would be unlawful.
Bayer Aktiengesellschaft
Post-stabilisation Period Announcement
Further to the capital increase announcement dated 3rd June 2018, Credit
Suisse Securities (Europe) Ltd (contact: Lloyd Adams; telephone: +44 207 888
6341) hereby gives notice that the Stabilisation Manager(s) named below
undertook no stabilisation activity (within the meaning of [Article 3.2(d)
of the Market Abuse Regulation (EU/596/2014) in relation to the offer of the
following securities, as set out below.
Issuer: Bayer Aktiengesellschaft
Guarantor (if any): N/A
Aggregate nominal amount: 74,604,156 shares
Description: Ordinary Shares
Stabilisation Manager(s): Credit Suisse Securities (Europe) Ltd
Offer price: EUR81.00
Stabilisation started: 6th June 2018
Stabilisation last occurred: 20th June 2018
Stabilisation trading venue XETRA
No stabilisation trading activity was undertaken
This announcement is for information purposes only and does not constitute
an invitation or offer to underwrite, subscribe for or otherwise acquire or
dispose of any securities of the Issuer in any jurisdiction.
This announcement is not an offer of securities for sale into the United
States. The securities have not been, and will not be, registered under the
United States Securities Act of 1933 and may not be offered or sold in the
United States absent registration or an exemption from registration. There
will be no public offer of securities in the United States.
This information is provided by RNS, the news service of the London Stock
Exchange. RNS is approved by the Financial Conduct Authority to act as a
Primary Information Provider in the United Kingdom. Terms and conditions
relating to the use and distribution of this information may apply. For
further information, please contact [email protected] or visit www.rns.com.
---------------------------------------------------------------------------
20.06.2018 Dissemination of a Corporate News, transmitted by DGAP - a
service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
The DGAP Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Archive at www.dgap.de
---------------------------------------------------------------------------
Language: English
Company: Credit Suisse Securities (Europe) Limited
Taunustor 1
60310 Frankfurt
Germany
Phone: +49 69 75380
E-mail: [email protected]
Internet: www.credit-suisse.com
ISIN: DE000BAY0017
WKN: BAY001
Listed: Foreign Exchange(s) SIX
End of News DGAP News Service
---------------------------------------------------------------------------
696875 20.06.2018
|
Weitere Ad-hoc und Unternehmensrelevante Mitteilungen zu
Credit Suisse Securities (Europe) Limited ISIN: DE000BAY0017 können Sie bei EQS abrufen
Gesundheit , BAY001 , BAYN , XETR:BAYN